Geraldine Henwood's Net Worth
$5.59 Million
Who is Geraldine Henwood?
Geraldine Henwood has an estimated net worth of $5.59 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Alkermes plc., Recro Pharma, Inc., Baudax Bio, Inc., ALKERMES INC, and AUXILIUM PHARMACEUTICALS INC.
SEC CIK
Geraldine Henwood's CIK is 0001236451
Past Insider Trading and Trends
2011 was Geraldine Henwood's most active year for acquiring shares with 13 total transactions. Geraldine Henwood's most active month to acquire stocks was the month of December. 2012 was Geraldine Henwood's most active year for disposing of shares, totalling 16 transactions. Geraldine Henwood's most active month to dispose stocks was the month of December. 2014 saw Geraldine Henwood paying a total of $616,200.00 for 782,500 shares, this is the most they've acquired in one year. In 2014 Geraldine Henwood cashed out on 80,000 shares for a total of $1,902,765.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MAP Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
$18.54 | -$129,350.00 |
0
|
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
$8.75 | -$65,572.40 |
0
|
Scheduled
|
Nov 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
$8.66 | -$136,668.70 |
0
|
Scheduled
|
Oct 27
| ||
Form 4
|
—
|
0
|
$6.76 | -$144,486.00 |
0
|
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
$4.71 | -$132,026.37 |
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alkermes plc. (ALKS) Snapshot price: $26.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
$31.49 | -$1,286,565.36 |
0
|
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$22.56 | -$364,732.00 |
0
|
Scheduled
|
Aug 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
$14.76 | -$249,232.00 |
0
|
Scheduled
|
Aug 24 - Aug 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
$13.41 | -$372,712.48 |
0
|
Feb 22 - Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Recro Pharma, Inc. (SCTL) No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
| +13.49% | 26.92K |
—
|
—
| 226.57K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 4
| -0.90% | -1.82K |
$3.03 | -$20,652.48 | 199.65K |
Jan 18
| |||
Form 4
| -2.70% | -5.60K |
$3.09 | -$17,300.91 | 201.47K |
Jan 2
| |||
Form 4
| -14.15% | -34.13K |
$2.30 | -$78,494.40 | 207.07K |
Dec 5
| |||
Form 4/A
|
—
|
0
|
$5.35 | -$460,000.00 | 241.19K |
Scheduled
|
Apr 17
| ||
Form 4
| -33.17% | -80.00K |
$8.22 | -$657,600.00 | 161.19K |
Scheduled
|
Apr 17
| ||
Form 4
| -0.23% | -552.00 |
$16.38 | -$90,941.76 | 241.19K |
Jan 18
| |||
Form 4
| -2.00% | -4.95K |
$17.53 | -$86,685.85 | 241.75K |
Jan 2
| |||
Form 4
| +61.09% | 93.55K |
—
|
—
| 246.69K |
Dec 5
| |||
Form 4
| -9.71% | -21.31K |
$5.68 | -$982,250.51 | 198.14K |
Scheduled
|
May 13
| ||
Form 4/A
| +25.39% | 44.44K |
$7.99 | -$11,385.75 | 219.45K |
Jan 18
| |||
Form 4
| +22.50% | 39.38K |
$7.99 | -$11,385.75 | 214.38K |
Jan 18
| |||
Form 4
| -2.36% | -4.22K |
$7.41 | -$31,292.43 | 175.01K |
Jan 2
| |||
Form 4
| -2.36% | -4.22K |
$7.41 | -$31,292.43 | 175.01K |
Jan 2
| |||
Form 4
| +1.95% | 3.42K |
$8.89 | -$14,001.75 | 179.23K |
Jan 18
| |||
Form 4
| +39.74% | 50K |
—
|
—
| 175.81K |
Jan 2
| |||
Form 4
| +20.39% | 21.31K |
$9.04 | -$88,537.76 | 125.81K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 17 - Jul 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +4.50% | 4.5K |
$8.92 | $40,136.50 | 104.5K |
Jun 5 - Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baudax Bio, Inc. (BXRX) Snapshot price: $0.0218
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +97.80% | 1.2K |
$2.55 | $3,057.12 | 2.43K |
Dec 15
| |||
Form 4
| +410.32% | 39.47K |
—
|
—
| 49.09K |
Jun 15
| |||
Form 4
| -5.24% | -18.64K |
$0.31 | -$5,777.16 | 336.72K |
Dec 15 - Dec 22
| |||
Form 4
| -2.51% | -9.15K |
$0.35 | -$3,204.25 | 355.35K |
Dec 5
| |||
Form 4
| +2.30% | 8.2K |
$0.59 | $4,797.82 | 364.51K |
Sep 22
| |||
Form 4
| +1.71% | 6K |
$0.83 | $4,992.00 | 356.31K |
May 7
| |||
Form 4
| +22.97% | 65.44K |
—
|
—
| 350.31K |
Jan 20
| |||
Form 4
| -22.57% | -83.02K |
$1.14 | -$94,637.10 | 284.87K |
Dec 5
| |||
Form 4
| +3.96% | 14.02K |
$8.51 | -$42,984.01 | 367.89K |
Jan 27
| |||
Form 4
| +1,083.11% | 323.96K |
—
|
—
| 353.87K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||